$SOTK
SONO TEK CORP

2025 Q1 Form 10-Q Financial Statement

#000117152025000009 Filed on January 13, 2025

View on sec.gov

Income Statement

Concept 2025 Q1 2024 Q4
Revenue $5.191M
YoY Change -8.78%
Cost Of Revenue $2.847M
YoY Change 3.02%
Gross Profit $2.343M
YoY Change -19.92%
Gross Profit Margin 45.14%
Selling, General & Admin $1.518M
YoY Change 6.19%
% of Gross Profit 64.78%
Research & Development $627.5K
YoY Change -19.13%
% of Gross Profit 26.78%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.146M
YoY Change -2.72%
Operating Profit $197.6K
YoY Change -72.57%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $314.0K
YoY Change -64.73%
Income Tax $39.81K
% Of Pretax Income 12.68%
Net Earnings $274.2K
YoY Change -60.27%
Net Earnings / Revenue 5.28%
Basic Earnings Per Share $0.02
Diluted Earnings Per Share $0.02
COMMON SHARES
Basic Shares Outstanding 15.75M shares 15.75M shares
Diluted Shares Outstanding 15.77M shares

Balance Sheet

Concept 2025 Q1 2024 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.68M
YoY Change 0.72%
Cash & Equivalents $8.099M
Short-Term Investments $4.582M
Other Short-Term Assets
YoY Change
Inventory $4.738M
Prepaid Expenses
Receivables $2.279M
Other Receivables
Total Short-Term Assets $19.82M
YoY Change 6.06%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $39.93K
YoY Change -22.73%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.515M
YoY Change 13.05%
TOTAL ASSETS
Total Short-Term Assets $19.82M
Total Long-Term Assets $4.515M
Total Assets $24.34M
YoY Change 7.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.117M
YoY Change -25.76%
Accrued Expenses $1.925M
YoY Change 11.92%
Deferred Revenue $3.363M
YoY Change 7.01%
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.619M
YoY Change 0.04%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.619M
Total Long-Term Liabilities
Total Liabilities $6.936M
YoY Change 4.84%
SHAREHOLDERS EQUITY
Retained Earnings $7.297M
YoY Change 17.8%
Common Stock $157.5K
YoY Change 0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.40M
YoY Change
Total Liabilities & Shareholders Equity $24.34M
YoY Change 7.29%

Cashflow Statement

Concept 2025 Q1 2024 Q4
OPERATING ACTIVITIES
Net Income $274.2K
YoY Change -60.27%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q3 sotk Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
usd
CY2023Q3 sotk Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
usd
CY2023Q4 sotk Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
sotk Purchases Of Equipment Included In Accounts Payable On Balance Sheet
PurchasesOfEquipmentIncludedInAccountsPayableOnBalanceSheet
usd
dei Local Phone Number
LocalPhoneNumber
795-2020
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15751153 shares
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2025Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15751153 shares
CY2024Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8098750 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2134786 usd
CY2024Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
4582428 usd
CY2024Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
9711351 usd
CY2024Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
12225 usd
CY2024Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2279304 usd
CY2024Q4 us-gaap Inventory Gross
InventoryGross
4737510 usd
CY2024Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
123298 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
207738 usd
CY2024Q4 us-gaap Assets Current
AssetsCurrent
19821290 usd
CY2024Q4 us-gaap Land
Land
250000 usd
CY2024Q4 sotk Buildings Equipment Furnishings And Leasehold Improvements Net
BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet
2713682 usd
CY2024Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
39931 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
47566 usd
CY2024Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1511459 usd
CY2024Q4 us-gaap Assets
Assets
24336362 usd
CY2024Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1116831 usd
CY2024Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1925036 usd
CY2024Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3363301 usd
CY2024Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
213350 usd
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
157512 usd
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6618518 usd
CY2024Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
317070 usd
CY2024Q4 us-gaap Liabilities
Liabilities
6935588 usd
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15751153 shares
CY2024Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9946460 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7296802 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
17400774 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24336362 usd
us-gaap Revenues
Revenues
15383416 usd
us-gaap Gross Profit
GrossProfit
7313783 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2054846 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2814804 usd
CY2024Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
929196 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1722210 usd
us-gaap Operating Expenses
OperatingExpenses
6591860 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
2205487 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
721923 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
359248 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
38776 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
174247 usd
CY2024Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39812 usd
us-gaap Profit Loss
ProfitLoss
945700 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15750980 shares
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1814990 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15744543 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15771039 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
16278998 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
54231 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
330837 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
16664066 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
42799 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
340685 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
17047550 usd
CY2024Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
79046 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
274178 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
17400774 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
14633958 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
48295 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
53406 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
14735659 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46394 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
541273 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
15323326 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
52745 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
690169 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
16066240 usd
us-gaap Profit Loss
ProfitLoss
945700 usd
us-gaap Profit Loss
ProfitLoss
1284848 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
529163 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
428345 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
176076 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
147434 usd
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
32524 usd
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
41475 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
38776 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
31031 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-167946 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-257777 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
808594 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
128443 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-451946 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1051116 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-84440 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-172261 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
67089 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
372175 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
185558 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
292574 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-56405 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
304844 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-201457 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-133269 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1199318 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1442320 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
403053 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
326577 usd
sotk Sale Of Marketable Securities
SaleOfMarketableSecurities
13740454 usd
sotk Sale Of Marketable Securities
SaleOfMarketableSecurities
14118735 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
8572755 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
15607148 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4764646 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5963964 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-372670 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2134786 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3354601 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8098750 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2981931 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
543814 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
712092 usd
sotk Purchases Of Equipment Included In Accounts Payable On Balance Sheet
PurchasesOfEquipmentIncludedInAccountsPayableOnBalanceSheet
321345 usd
CY2024Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
4055000 usd
CY2024Q4 us-gaap Marketable Securities
MarketableSecurities
4582428 usd
CY2024Q1 us-gaap Marketable Securities
MarketableSecurities
9711351 usd
CY2024Q4 us-gaap Marketable Securities
MarketableSecurities
4582428 usd
CY2024Q1 us-gaap Marketable Securities
MarketableSecurities
9711351 usd
CY2024Q4 sotk Accruals For Uncertain Tax Positions
AccrualsForUncertainTaxPositions
0 usd
CY2024Q1 sotk Accruals For Uncertain Tax Positions
AccrualsForUncertainTaxPositions
0 usd
CY2024Q4 us-gaap Land
Land
250000 usd
CY2024Q1 us-gaap Land
Land
250000 usd
CY2024Q4 sotk Buildings Equipment Furnishings And Leasehold Improvements Net
BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet
2713682 usd
CY2024Q1 sotk Buildings Equipment Furnishings And Leasehold Improvements Net
BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet
2832156 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zkIODJLFI56d" style="font: 10pt Cambria,serif; margin: 0"><b><i><span id="xdx_86B_zCAstBQZH5t1">Management Estimates</span></i></b> - The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024Q4 sotk Cash Deposits
CashDeposits
3363000 usd
CY2024Q1 sotk Cash Deposits
CashDeposits
3420000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3320000 usd
CY2024Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2459979 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
2270567 usd
CY2024Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1228517 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1785952 usd
CY2024Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1049014 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
1165461 usd
CY2024Q4 us-gaap Inventory Net
InventoryNet
4737510 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
5221980 usd
CY2024Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
349300 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
380400 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.54
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2024Q4 us-gaap Share Based Compensation
ShareBasedCompensation
79000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
53000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
176000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
147000 usd
CY2024Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
484000 usd
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
126000 usd
us-gaap Profit Loss
ProfitLoss
945700 usd
us-gaap Profit Loss
ProfitLoss
1284848 usd
CY2024Q4 us-gaap Profit Loss
ProfitLoss
274178 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
690169 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15750980 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15743224 shares
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15751153 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15744543 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
20059 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
32451 shares
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
20358 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
32429 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15771039 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15775675 shares
CY2024Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15771511 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15776972 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2024Q4 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0775 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5974000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5944000 usd
CY2024Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2368000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2269000 usd
CY2024Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2024-11-30
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1119947 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-16035
CY2024Q1 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
12225 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15750880 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15750880 shares
us-gaap Cost Of Revenue
CostOfRevenue
8069633 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
dei Entity Central Index Key
EntityCentralIndexKey
0000806172
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
SONO TEK CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
14-1568099
dei Entity Address Address Line1
EntityAddressAddressLine1
2012 Rt. 9W
dei Entity Address City Or Town
EntityAddressCityOrTown
Milton
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
12547
dei City Area Code
CityAreaCode
845
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
SOTK
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1470711 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
5221980 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
18746566 usd
CY2024Q1 us-gaap Land
Land
250000 usd
CY2024Q1 sotk Buildings Equipment Furnishings And Leasehold Improvements Net
BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet
2832156 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1255977 usd
CY2024Q1 us-gaap Assets
Assets
23132265 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1049742 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1739478 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3419706 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
414807 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6623733 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
229534 usd
CY2024Q1 us-gaap Liabilities
Liabilities
6853267 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
157509 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9770387 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6351102 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
16278998 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23132265 usd
us-gaap Revenues
Revenues
14932157 usd
CY2024Q4 us-gaap Revenues
Revenues
5190596 usd
CY2023Q4 us-gaap Revenues
Revenues
5690022 usd
us-gaap Cost Of Revenue
CostOfRevenue
7428348 usd
CY2024Q4 us-gaap Cost Of Revenue
CostOfRevenue
2847397 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
2764013 usd
us-gaap Gross Profit
GrossProfit
7503809 usd
CY2024Q4 us-gaap Gross Profit
GrossProfit
2343199 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
2926009 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2221712 usd
CY2024Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
627543 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
776013 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2700327 usd
CY2023Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
955017 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1387006 usd
CY2024Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
588823 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
474457 usd
us-gaap Operating Expenses
OperatingExpenses
6309045 usd
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
2145562 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1194764 usd
CY2024Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
197637 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
720522 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
379949 usd
CY2024Q4 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
131518 usd
CY2023Q4 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
149666 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
31031 usd
CY2024Q4 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-15165 usd
CY2023Q4 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
20176 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1605744 usd
CY2024Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
313990 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
890364 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
320896 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200195 usd
us-gaap Profit Loss
ProfitLoss
1284848 usd
CY2024Q4 us-gaap Profit Loss
ProfitLoss
274178 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
690169 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15743224 shares
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15751153 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15775675 shares
CY2024Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15771511 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15776972 shares

Files In Submission

Name View Source Status
0001171520-25-000009-index-headers.html Edgar Link pending
0001171520-25-000009-index.html Edgar Link pending
0001171520-25-000009.txt Edgar Link pending
sotk-20241130_cal.xml Edgar Link unprocessable
0001171520-25-000009-xbrl.zip Edgar Link pending
eps11676_sotk.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sonotek-logo.jpg Edgar Link pending
sotk-20241130.xsd Edgar Link pending
sotk-20241130_def.xml Edgar Link unprocessable
sotk-20241130_lab.xml Edgar Link unprocessable
eps11676_sotk_htm.xml Edgar Link completed
sotk-20241130_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable